Epidermal fatty acid-binding protein (E-FABP), previously characterized in human keratinocytes, is a cytoplas mic protein of 15 kD that specifically binds fatty acids (FAs), Previous PAGE-immunoblotting studies indicated that several human tissues display an immunoreactive band with an elec trophoretic mobility identical to that of E-FABP. The aim of this study was to determine in which cells, other than kerati nocytes, E-FABP might be expressed-By immunohis to chemis try, we show that E-FABP is expressed in endothelial cells of the microvasculature of the placenta, heart, skeletal muscle, small intestine, lung, and renal medulla. Interestingly, in lung, a tissue of endodermal origin, E-FABP staining was also T he FABPs constitute a superfamily of highly conserved 14-to 15-kD cytosolic lipid-binding proteins. These specific carriers are widely dis tributed among different cell types and are involved in the transport of long chain FAs. Several observations suggest that the major function of FABPs is to regulate intracellular levels of FAs and their targeting to specific metabolic pathways.1-3 FAs are important molecules for membrane formation, energy delivery, and lipid media tion. It has recently been suggested that FABPs may also interact with several FA-mediated cellular processes, such as control of cell growth, cell signaling, and regu lation of gene transcription (reviewed in References 2, 4, 5, and 6). At least eight FABP types can be discrimi nated and have been named after the first tissue in which they were identified.1-3 Each FABP type displays a characteristic pattern of tissue expression and distinct ligand-binding properties, suggesting specific and com plementary functions for each protein.
logical conditions, and in cultured keratinocytes.8,9 PAGE-autoradioblotting and PAGE-immunoblotting studies of various human tissues revealed that E-FABP expression is not restricted to keratinocytes, since heart, intestine, and adipose tissue showed an immunore active band with an electrophoretic mobility identical to that of E-FABP from keratinocytes.7'8 To date, the cellular localization of E-FABP in nonepithelial tissues is un known. Furthermore, it has not been established whether E-FABP from keratinocytes is identical to the immunoreactive band detected in other tissues.
In the present study, we show that E-FABP is ex pressed in nonciliated cells of the bronchial epithelium and in endothelial cells of the microvasculature of several tissues. By molecular cloning, we show that endothelial E-FABP is identical to keratinocyte E-FABP. The possible role of E-FABP in blood capillary function is discussed.
M aterials and M ethods Tissue Specimens
Specimens from human heart, small intestine, skeletal mus cle (quadriceps), lung, and kidney were obtained from autop sies (Department o f Pathology, University Hospital, Geneva, Switzerland) and from biopsies obtained during surgery. Pla centa and umbilical cord specimens were obtained immediately after obstetrical delivery.
Immunohistochemistry
Tissue samples were fixed for at least 24 hours in 10% formalin or Duboscq-Brazil solution and processed for routine histology. None of the tissues showed obvious pathological alterations by conventional hematoxylin-eosin staining. Rabbit antiserum against human E-FABP purified from psoriatic scales was obtained as described previously. 8 immunoblotting analysis showed only one immunoreactive band at 15 kD and R f (relative mobility) 0.32, respectively. 8 Paraffin sections (5 /Am) were permeabilized in 0.3% Triton X-100 solution and preincubated with normal goat serum to block nonspecific binding sites. After incubation for 60 minutes at room temperature with the anti-E-FABP antiserum (dilu tion, 1:200), an immunoperoxidase technique using a biotinylated goat anti-rabbit IgG as secondary antibody and a perox idase-conjugated avidin-biotin complex was applied according to the manufacturer's instructions (Vectastain reagents, Vector Laboratory). Peroxidase reactivity was then revealed using hydrogen peroxide and diaminobenzidine as a chromogenic substrate. The sections were lightly counterstained with hema toxylin. As a control, preimmune serum from the immunized rabbit was used simultaneously on adjacent sections.
We performed comparative stainings on adjacent sections using vWF and UEA1 as endothelial markers, together with a standard immunoperoxidase technique, vWF was detected using a rabbit antiserum directed against human vWF (factor VUI-related antigen, Dakopatts). Biotinylated swine anti-rab bit immunoglobulins (E353, Dako A/S) and a peroxidaseconjugated streptavidin-biotin complex (StreptABComplex/ HRP, Dako A/S) were then applied according to the manufacturer's instructions. For UEA1 staining, we used a biotinylated U E A 1 (Vector Laboratories) and a peroxidaseconjugated streptavidin-biotin complex (StreptABComplex/ HRP, Dako A/S). The peroxidase was localized by the diami nobenzidine-hydrogen peroxide reaction, and the sections were lightly counterstained with hematoxylin. 
Endothelial Cell Cultures

DM VECs
Normal DMVECs isolated from foreskin (Invitrocyte Inc) were grown in MEM (a modification, GIBCO BRL) and 10% donor calf serum (GIBCO BRL).
PAGE-immunoblotting Analysis
Nonpathological heart and small intestine biopsies as well as cultured endothelial cell lines (HUVECs and DMVECs) were analyzed for E-FABP expression by PAGE-immunoblotting techniques under non denaturing conditions as described pre viously.10 Purified E-FABP8 was used as a standard. Rabbit antiserum against human E-FABP was used to detect E-FABP.8 Similar experiments were performed using antisera directed against H-FABP and L-FABP.11 
Cloning of E-FABP From Human Endothelial Cells
RNA Isolation and cDNA Synthesis
Southern Blotting, Cloning, and Sequencing of PCR Products
The amplified cDNA fragments were separated in a 1,5% agarose gel and detected by ethidium bromide staining (0.5 fjbg/mL). A 100-bp D N A ladder from GIBCO served as a molecular standard. Transfer of separated DNA onto a Hybond N filter (Amersham) and prehybridization were per formed as described previously.14 A full-lengh PA-FABP cDNA was labeled using the Prime-a-Gene labeling kit from Promega according to the manufacturer's instructions. Hybridization with the labeled cDNA probe was performed overnight at 65°G The filter was washed first at room temperature in 2X SSC/ 0.1% SDS for 30 minutes and 0.5X SSC/0.1% SDS for 30 minutes and then at 60Q C in 0.1 X SSC/0.1% SDS for 30 minutes and subsequently exposed to x-ray film. Cloning of the PCR products was done using the TA-cloning kit from Invitrogen according to the manufacturer's instructions. Plasmids were isolated, and inserts were subsequently sequenced using the T7 sequencing kit from Pharmacia. 
Results
Immunolocalization of E-FABP in Human Tissues
Controls
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Placenta at Term
Trophoblastic cells lining the placental villi were immunonegative. The endothelium stained strongly for E-FABP in a high proportion of fetal microvessels, including capillaries and venules (estimated to be >85% of vascular cross sections) ( Fig IB) . Endothelium of small veins was occasionally positive.
Skeletal Muscle
Muscle cells from quadriceps did not express E-FABP. In contrast, the endothelial cells from the microvasculature surrounding the muscle fibers were clearly positive ( Fig 1C) .
Heart
No significant staining was observed in cardiomyocytes or endocardial endothelial cells, but the microvascular endothelium expressed E-FABP ( Fig ID) .
Small Intestine
The epithelium lining the intestinal crypts and villi was negative for E-FABP, whereas capillaries localized in these villi were strongly immunoreactive ( Fig IE) » Venules identified in the mucosa were negative. The microvasculature was positive in the submucosa (not shown).
Adipose Tissue
In adipose tissue of the intestinal wall, heart, and hypodermis* capillaries surrounding adipocytes as well as small collecting venules ( Fig IF) always exhibited intense immunostaining. On these paraffin-embedded sections, adipocytes did not demonstrate significant la beling (not shown).
Umbilical Cord
Umbilical cord vasculature consists of two arteries and a single vein that are devoid of vasa vasorum; E-FABP .. was not detected in the endothelium of any of the umbilical vessels (Fig 1G and lH) ,The amniotic epithe lium lining the umbilical cord expressed E-FABP (not shown). 1G and 1H) were immunonegative.
Smooth Muscle Smooth muscle cells in the intestinal wall and in blood vessels (Fig
Liver
No significant reactivity was detected in liver (not shown).
Kidney
The renal excretory system was immunonegative. In the cortex, the great majority of the vessels, including glomeruli and their afferent and efferent arterioles, were not stained (Fig 2A) ; only rare capillaries were faintly positive (estimated at <5% compared with UEA1 stain ing). In the medulla, E-FABP was detected in the endothelium of a subpopulation of peritubular capillar ies (estimated at 80% compared with UEA1 staining), Vasa recta were negative (Fig 2B) .
Lung
In bronchial epithelium, ciliated cells were immuno negative, whereas goblet cells expressed E-FABP ( Fig  3A) , E-FABP was also detected in a subpopulation of alveolar epithelial cells, most probably type 2 pneumo cytes ( Fig 3B) . The peribronchial microvasculature was positive, and the alveolar capillaiy network was partially *The percentage of microvessels positive for E-FABP, vWF, and UEA1 was 85%, 75%, and 40%, respectively (estimated by vascular cross sections). tSmall veins occasionally stained. More than 95% of the cortical microvasculature, including glomeruli, was negative for E-FABP. In renal medulla, 80% of the peritubular capillaries were positive for E-FABP (compared with UEA1 staining). stained (Fig 3B) . Clara cells in terminal bronchioles were also labeled (Fig 3C and 3D) . Fig IF) . 
Comparative Study of E-FABP, vWF, and UEA1 in Endothelial Cells of Various Tissues
Comparative Stainings of E-FABP, vWF, and UEA1 in Various Organs vWF and UEA1 were used to stain endothelial cells in order to compare their distribution with E-FABP. These data, summarized in the Table, revealed that E-FABP, vWF, and UEA'l had distinct expression patterns in endothelial cells from different tissues. Depending on the organ studied as well as the local ization of the vasculature in each organ, a variable number of capillaries and venules were strongly E-FABP positive. Although small arterioles were relatively diffi cult to identify on routine histological sections, E-FABP was not detected in this compartment of the microvas culature. Pericytes did not express E-FABP (
As a general rule, in all organs studied, E-FABP was not detected in large blood vessels, including arteries, arterioles with internal elastic lamina, and large veins. Endothelial cells of small veins were only occasionally stained. A representative experiment comparing E-FABP and UEA1 expression in kidney vasculature is illustrated in
Expression of E-FABP in Human Endothelial Cells
When protein extracts from intestine (Fig 4A, lanes 1  and 2), heart (lanes 3 and 4), HUVECs (lanes 5 and 6) , and DMVECs (lanes 9 and 10) (20 fig and 40 Fig 4A were performed but  with antisera against H-FABP (Fig 4B) and L-FABP  (Fig 4C) . Immunoreactive bands of H-FABP and L-FABP were detected in heart and intestine samples, respectively, whereas these FABPs could not be de tected in HUVECs and DMVECs. Moreover, no cross reactivity with E-FABP was observed.
jag loaded for each sample) were analyzed by PAGE-immunoblotting with antiserum directed against E-FABP, the immunoreactive band detected in these samples showed an electrophoretic mobility identical to purified E-FABP (lane 7 [0.5 ¡¿g] and lane 8 [0.01 /xg]), suggesting that E-FABP from the various tissues and cell lines is similar to E-FABP from keratinocytes. By comparing the inten sity of the purified E-FABP bands with bands from other samples, it was estimated that the amount of E-FABP per total protein ranges between 0.5% and 2%. Exper iments similar to those in
Cloning of E-FABP From Human Endothelial Cells
In order to determine whether E-FABP transcripts are also expressed in human endothelial cells (HUVECs and DMVECs), we performed RT-PCR analysis using primers based on the sequence that has recently been published for PA-FAB P.™ Separation of the RT-PCR products by agarose gel electrophoresis and ethidium bromide staining revealed cDNA fragments of the ex pected sizes (a 380-bp fragment for reaction 1 and a 472-bp fragment for reactions 2 and 3; see Fig 5A) . Southern blotting using the radiolabeled PA-FABP fulllength cDNA as a probe further confirmed the expres sion of E-FABP in endothelial cells (Fig 5B) . In addition, the RT-PCR products were cloned, and both strands of the cDNA were sequenced, revealing that the E-FABP and endothelial FABP are identical (data not shown).
Discussion
By immunohistochemistry, we have demonstrated that endothelial cells account for the immun ore active band similar to E-FABP, previously detected in human heart, intestine, and adipose tissue by PAGE-immunoblotting analysis.7'8 By cloning and sequencing of an E-FABP cDNA from cultured human endothelial cells (HUVECs and DMVECs), we have demonstrated that endothelial E-FABP is identical to keratinocyte E-FABP. 13 FABPs are generally abundant in tissues, ranging between 0.1% and 6% of total protein.1'3 We previously reported that E-FABP is an exception, since its levels, as measured by binding capacity, were low in normal human tissues compared with other tissue FABPs. Using PAGE-immunoblotting analysis, we have shown that E-FABP is expressed at relatively high levels, ranging from 0.5% to 2% of total protein in tissues, HUVECs, and DMVECs. The discrepancy between the values of these two measurements could be explained by posttranslational modifications of E-FABP, which lower the affinity for tritiated oleic acid used as a tracer. 8 We found that HUVECs express significant amounts of E-FABP, whereas the endothelium of umbilical vein, from which HUVECs are isolated, was negative by immunohistochemistry. Therefore, when endothelial cells are isolated from tissues and are subsequently cultured, they are likely to modify their ability to express E-FABP. Similar observations have been reported with H-FABP, and this may in part explain the controversy concerning the presence or the absence of FABPs in endothelial cells: several immuno his to logical studies have demonstrated that H-FABP is widely distributed in microvascular endothelial cells from various mammalian tissues15'1722; however, the amounts of H-FABP in en dothelial cells isolated from human umbilical artery,11 rat heart,11* 21'22 and bovine aorta23 have shown consider able variations, and in the present study, we did not find H-FABP expression in any of our endothelial cultures.
Linssen et al22 reported a discrepancy between high FA oxidation by isolated cardiac endothelial cells and their low content of H-FABP; they hypothesized that two FABP types have to be present in the heart (one localized in cardiomyocytes and a second in endothelial cells) or that during culturing, endothelial cells might lose their capacity to express H-FABP. However, the presence of E-FABP in cultured DMVECs was in accordance with its immunodetection in the dermal microvasculature on skin sections (authors5 unpublished data, 1996). On the other hand, E-FABP could not be detected in transformed endothelial cells (HMEC-1), suggesting that this phenotype is lost during the trans formation process (data not shown). We hypothesized that FABP expression in isolated endothelial cells might be conditioned by the tissue of origin and by environ mental factors such as culture conditions. These data further indicate that conclusions about the in vivo con tent of FABPs in endothelial cells and about their putative functions should not be extrapolated exclusively from studies in vitro.
The lung was the only organ in which cell types other than endothelial cells and keratinocytes revealed E-FABP staining. Further biochemical investigation will allow us to determine whether this staining is due to the expression of E-FABP. The strongly stained Clara cells, goblet cells, and probably pneumocytes are implicated in the secretion of surfactant, muccopolysaccharides, and other components of lung fluid, respectively. Whether E-FABP might play a role in the secretory functions of these endoderm-derived cells remains to be elucidated.
The present study has shown that endothelial E-FABP is restricted to the microvasculature of various tissues, whereas larger blood vessels with muscular walls are usually immunonegative. Furthermore, not all capillar ies contained E-FABP, as shown by the absence of staining in liver and kidney cortex. The heterogeneity of endothelial cells is now well established: small-vessel endothelial cells are phenotypically, biochemically, and functionally different from large-vessel endothelial cells.
Variations concerning specific in vivo functions also exist between endothelial cells derived from different or gans.24 Our results indicate that E-FABP expression in endothelial cells is related to the size of the vessels and to the nature of the tissue surrounding the endothelial cells. They indirectly suggest that E-FABP-mediated FA metabolism and/or transport occurs at the level of the micro vasculature in several target organs and that E-FABP expression might also be regulated by processes implicated in cell differentiation.
Microvascular endothelial cells play a central role in the delivery of nutrients such as FA to tissues. It is generally assumed that FAs are transported from the blood compartment to the interstitium directly through the cytoplasm of endothelial cells. Several mechanisms probably contribute to FA transfer across the vascular barrier, but they remain poorly understood21; the in volvement of endothelial H-FABP has been hypothe sized,19 but this remains controversial.21 Interestingly, E-FABP is strongly expressed in capillary endothelial cells of several tissues that participate actively in the metabolism of FA, in locations where an important traffic of free FA occurs from the blood compartment to tissue cells (and/or vice versa): around adipocytes, serv ing as lipid storage cells and as a readily available source o f energy; in the small intestine, where intestinal FAs are absorbed; and in the microvasculature of heart and skeletal muscles, which require high levels of bloodderived FA for energy. It is noteworthy that a complex pattern of FA metabolism and transport also occurs in the placenta,25 which contains several FABP types.11*15-18'26 This organ has a high FA requirement for its own energy and structural needs and for supplying FAs to the fetus. Since fetal capillaries from placental villi strongly express E-FABP, this protein may be important for the transfer of free FAs from maternal blood to the fetus. Our data support the idea that E-FABP is involved in the uptake and transport of free FAs across the endothelial cytoplasm. The presence of E-FABP in endothelial cells of the microvasculature might also suggest that these cells must undergo FAmediated activation to perform their functions of uptake and release of various metabolites.
